May M, Protzel C, Vetterlein M W, Gierth M, Noldus J, Karl A, Grimm T, Wullich B, Grimm M O, Nuhn P, Bastian P J, Roigas J, Hadaschik B, Gilfrich C, Burger M, Fisch M, Brookman-May S, Aziz A, Hakenberg O W
Department of Urology, St. Elisabeth-Hospital Straubing, St. Elisabeth-Straße 23, 94315, Straubing, Germany.
Department of Urology, University of Rostock, Rostock, Germany.
Int Urol Nephrol. 2017 Feb;49(2):247-254. doi: 10.1007/s11255-016-1469-7. Epub 2016 Nov 28.
To evaluate the possible association between bladder tumor location and the laterality of positive lymph nodes (LN) in a prospectively collected multi-institutional radical cystectomy (RC) series.
The study population included 148 node-positive bladder cancer (BC) patients undergoing RC and pelvic lymph node dissection in 2011 without neoadjuvant chemotherapy and without distant metastasis. Tumor location was classified as right, left or bilateral and compared to the laterality of positive pelvic LN. A logistic regression model was used to identify predictors of ipsilaterality of lymphatic spread. Using multivariate Cox regression analyses (median follow-up: 25 months), the effect of the laterality of positive LN on cancer-specific mortality (CSM) was estimated.
Overall, median 18.5 LN [interquartile range (IQR), 11-27] were removed and 3 LN (IQR 1-5) were positive. There was concordance of tumor location and laterality of positive LN in 82% [95% confidence interval (CI), 76-89]. Patients with unilateral tumors (n = 78) harbored exclusively ipsilateral positive LN in 67% (95% CI 56-77). No criteria were found to predict ipsilateral positive LN in patients with unilateral tumors. CSM after 3 years in patients with ipsilateral, contralateral, and bilateral LN metastasis was 41, 67, and 100%, respectively (p = 0.042). However, no significant effect of the laterality of positive pelvic LN on CSM could be confirmed in multivariate analyses.
Our prospective cohort showed a concordance of tumor location and laterality of LN metastasis in BC at RC without any predictive criteria and without any influence on CSM. It is debatable, whether these findings may contribute to a more individualized patient management.
在一项前瞻性收集的多机构根治性膀胱切除术(RC)系列研究中,评估膀胱肿瘤位置与阳性淋巴结(LN)侧别之间的可能关联。
研究人群包括2011年接受RC和盆腔淋巴结清扫的148例淋巴结阳性膀胱癌(BC)患者,这些患者未接受新辅助化疗且无远处转移。肿瘤位置分为右侧、左侧或双侧,并与阳性盆腔LN的侧别进行比较。采用逻辑回归模型确定淋巴转移同侧性的预测因素。使用多变量Cox回归分析(中位随访时间:25个月),评估阳性LN侧别对癌症特异性死亡率(CSM)的影响。
总体而言,共切除中位18.5枚LN[四分位间距(IQR),11 - 27],3枚LN(IQR 1 - 5)为阳性。肿瘤位置与阳性LN侧别一致的比例为82%[95%置信区间(CI),76 - 89]。单侧肿瘤患者(n = 78)中,67%(95% CI 56 - 77)仅存在同侧阳性LN。未发现可预测单侧肿瘤患者同侧阳性LN的标准。同侧、对侧和双侧LN转移患者3年后的CSM分别为41%、67%和100%(p = 0.042)。然而,多变量分析中未证实阳性盆腔LN侧别对CSM有显著影响。
我们的前瞻性队列研究显示,在RC时BC的肿瘤位置与LN转移侧别存在一致性,但无任何预测标准,且对CSM无任何影响。这些发现是否有助于更个体化的患者管理仍存在争议。